Posts

ulrich medical USA® Brings Strong Momentum® to U.S. Product Launch

Announces Nationwide Rollout of Innovative Rod-Screw System

ST. LOUIS, MO (July 13, 2020) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States announced the nationwide commercial release of the Momentum Posterior Spinal Fixation System.

“After completing hundreds of procedures during the alpha launch, Momentum has already made its mark with an enthusiastic reception and positive reviews from our alpha surgeon users,” said Erika Strecker-Laskey, Chief Commercial Officer, ulrich medical USA. “Even amid the healthcare challenges presented by the Covid-19 crisis, we have seen steadily-increasing use of Momentum during this time and a growing demand for more sets.”

Dr. Christopher F. Wagener of Allentown, PA performed multiple procedures with Momentum during the alpha launch period and said, “Momentum gives surgeons exactly what they need, both simplicity and reliability.”

Developed in St. Louis, Missouri, the new Momentum rod-screw system includes polyaxial, reduction, and iliac screws, and is compatible with ulrich medical USA’s neon3® Universal OCT Spinal Stabilization System via transition rods and connectors. This offering allows for surgical constructs capable of bridging from the sacroiliac to the cervical spine. All screws for the Momentum System are offered in a range of lengths, diameters, and angulations to accommodate unique patient anatomy. Screws are available from Ø 4.5mm to Ø 10.0mm, and in lengths from 25mm to 110mm. The system also offers both titanium and cobalt chrome rods (curved and straight) in Ø 5.5mm and Ø 6.0mm diameters. Single-use drills and taps guarantee consistent instrument performance for optimized clinical results. In addition, specialty surgical instrument modules are available for iliac fixation and deformity (basic) applications.

ulrich medical USA® Gains Momentum® in the U.S. Spine Implant Market

Demonstrates Continued Innovation with Market Entry of New Flagship Rod-Screw System

ST. LOUIS, MO (December 6, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today the commercial release of its inaugural rod-screw system which was developed in St. Louis, Missouri. The Momentum Posterior Spinal Fixation System is the newest addition to ulrich medical USA’s growing portfolio of industry-leading spine surgery solutions.

Read more

ulrich medical USA®Announces Landmark Achievement 100,000 VBR Implant Milestone

Solidifies Spine Market Leadership Position in Vertebral Body Replacement Devices   

ST. LOUIS, MO (June 12, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today that the company enterprise will surpass the 100,000 implant milestone in 2019 in total vertebral body replacement (VBR) device implantations.

Read more

ulrich medical USA®Announces Strong Continued Growth of U.S. Spine Business

Delivers 13 Consecutive Years of Organic Growth and Double Digit Positive EDITDA

ST. LOUIS, MO (April 16, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2018 financial results which continue the company’s achievement of significant year-over-year organic growth for thirteen consecutive years (since 2006).

Read more

ulrich medical USA® Delivers Seventh Consecutive Year of Profitable Double-Digit Growth

Reports 15%, 5-Year Revenue CAGR Performance in U.S. Spine Market

ST. LOUIS, MO (March 7, 2018) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2017 financial results with 10% annual revenue growth for the year ending December 31, 2017 and a 15%, 5-year compound annual growth rate (CAGR) in their U.S. spine market business.

Read more

ulrich medical USA® Triples U.S. Spine Business

Delivers Solid Growth, Revenue Diversification, and Continued Profitability

ST. LOUIS, MO (April 18, 2017) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported full year 2016 financial results with a 15% top line revenue increase for the year ending December 31, 2016 and a 20% growth in EBITDA for the same period.

Read more

ulrich medical USA® Announces Strong Financial Performance of U.S. Spine Business

Delivers Record-Breaking 5-Year Results ~ 18% Revenue CAGR and 27% EBITDA CAGR

ST. LOUIS, MO (February 17, 2016) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported a fifth consecutive year of profitable, double-digit growth for the U.S. spine business and a 20% top line growth for the year ending December 31, 2015. Equally as strong, the company announced a 5-year revenue compound annual growth rate (CAGR) of 18% and a 27% EBITDA CAGR over the same period.

Read more

ulrich medical USA® Settles Lawsuit against Amedica®

Amedica Agrees to $75,000 Settlement Payment

ST. LOUIS, MO (December 7, 2015) – ulrich medical USA, Inc. (ulrich) today announced it has reached a settlement with Amedica Corporation (Nasdaq: AMDA) in association with a lawsuit that ulrich filed against Amedica alleging a variety of infractions related to the hiring by Amedica of a former ulrich sales director that ulrich alleged violated the former sales director’s Employment Agreement with ulrich, including its confidentiality and noncompetition provisions.

Read more

ulrich medical USA® Announces North American Corporate Expansion

Twenty Percent Growth Year-to-Date Caps Four Years of Exceptional U.S. Performance

ST. LOUIS, MO (August 24, 2015) – ulrich medical USA Inc., today announced plans to significantly increase its U.S. workforce in order to accommodate for the increasing demands of its dynamic spine implant business. Fueled by four consecutive years of profitable, double-digit growth and twenty percent year-to-date growth, the company is investing in its future and expanding across multiple functional areas within North America.

Read more

ulrich medical USA® Delivers Four Consecutive Years of Double-Digit Growth

ST. LOUIS, MO (March 2, 2015) – ulrich medical USA Inc., today announced a strong financial performance for the year ending December 31, 2014. The company recorded a 15 percent annual growth rate in 2014, which caps off four consecutive years of profitable, double-digit growth for the company.

Read more